Table 1. Details of patient demographics and immunological status in the abacavir-hypersensitive and -tolerant groups.
| Sex, n (%)
|
Ethnicity, n (%)
|
||||||
|---|---|---|---|---|---|---|---|
| M | F | E | NE | Mean age, years (SD) | Mean CD4+ count, cells per μl (SD) | Mean CD8+ proportion, % (SD) | |
| Hypersensitive, n = 18 | 15 (83) | 3 (17) | 18 (100) | 0 | 45.0 (10.3) | 446 (299) | 51.8 (12.1) |
| Tolerant, n = 230 | 197 (86) | 33 (14.3) | 196 (85) | 34 (15) | 42.6 (10.3) | 435 (284) | 51.5 (12.1) |
P values follow for male (M) abacavir-hypersensitive and -tolerant individuals, abacavir-hypersensitive and -tolerant individuals of European descent (E), mean age, mean CD4+ T cell count, and mean CD8+ T cell proportion: 0.73, 0.15, 0.35, 0.85, and 0.92, respectively. F, female; NE, individuals of non-European descent.